Whether GLIPR1 promoter methylation is dynamic during disease progression or shows higher or lower levels of methylation in metastatic melanoma cells compared to normal melanocytes, benign nevi and primary melanoma remains unknown and requires further investigation. Here, GLIPR1 is linked to metastatic melanoma.